超声心动图应变对局部晚期非小细胞肺癌放疗后不良结局的预测及附加价值
前瞻性纳入112例拟接受放疗的III期非小细胞肺癌患者,放疗后即刻及6个月均观察到整体纵向应变(GLS)下降。多因素分析显示,基线至6个月GLS变化百分比(ΔGLS%6m-RT)是全因死亡的独立预测因子(HR=1.202,95%CI 1.095-1.320,p<0.001)。ΔGLS%6m-RT≥13.65%预测死亡的敏感度65.9%、特异度85.2%(AUC=0.784,95%CI 0.692-0.876,p<0.001)。
要点
- 放疗后6个月GLS较基线下降,ΔGLS%6m-RT≥13.65%预测死亡敏感度65.9%、特异度85.2%。
- ΔGLS%6m-RT是全因死亡的独立预测因子(HR=1.202,95%CI 1.095-1.320,p<0.001)。
- 作者认为这些发现应鼓励医生在放疗后早期进行超声心动图检查。
核心结论
- 放疗后早期及6个月均可观察到GLS下降,ΔGLS%6m-RT是全因死亡的独立预测因子,作者认为应鼓励放疗后早期行超声心动图检查。
研究设计与样本
- 前瞻性研究,纳入112例拟接受放疗的III期非小细胞肺癌患者,采用斑点追踪超声心动图评估放疗后亚临床心肌功能障碍。
关键影像表现/征象
- 放疗后即刻及放疗后6个月均观察到整体纵向应变(GLS)较基线下降。
诊断标准与关键数值
- ΔGLS%6m-RT≥13.65%预测非小细胞肺癌患者死亡的敏感度65.9%、特异度85.2%(AUC=0.784,95%CI 0.692-0.876,p<0.001)。
临床应用与阅片要点
- 作者认为这些发现应鼓励医生在放疗后早期进行超声心动图检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiotherapy (RT) is potentially related to cardiotoxicity, which may partially offset the benefits of cancer treatment. We sought to evaluate subclinical myocardial dysfunction using speckle tracking echocardiography after RT and to explore the associations between early cardiac effects and adverse outcomes in patients with non-small cell lung cancer (NSCLC). In total, 112 patients with stage III NSCLC who were scheduled to receive RT were prospectively recruited. A reduction in global longitudinal strain (GLS) was observed immediately after RT and at 6 mo after RT (6 m-RT). In multivariable analysis, the percentage change in GLS from baseline to 6 mo (ΔGLS%6 m-RT) (hazard ratio = 1.202, 95% confidence interval: 1.095-1.320, p < 0.001) was an independent predictor of all-cause mortality. Based on receiver operating characteristic curve analysis, ΔGLS%6 m-RT ≥13.65% had 65.9% sensitivity and 85.2% specificity for predicting mortality in NSCLC patients (area under the curve = 0.784, 95% confidence interval: 0.692-0.876, p < 0.001). These findings should encourage physicians to perform echocardiography early after RT.
引用
- Chen L, Ta S, Wu W, et al. Prognostic and Added Value of Echocardiographic Strain for Prediction of Adverse Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer after Radiotherapy. Ultrasound Med Biol. 2018. PMID: 30366608. doi:10.1016/j.ultrasmedbio.2018.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。